Podcasts about Obstructive sleep apnea

Obstructive sleep apnea (OSA) is an increasingly common diagnosis. Yet most behavioral health providers are unaware that they can play a role in both the assessment and treatment of OSA in their patients. Today we're joined by an expert in the subfield of sleep psychology, Dr. Phil Gehrman. He shares basic information about what OSA is, how providers can effectively screen for it, and how they can facilitate treatment for this dangerous condition. Despite what you might have heard before, Dr. Gehrman posits that behavioral health providers can play “a huge potential role that really is untapped.” Dr. Phil Gehrman is Professor of Psychology in the Department of Psychiatry of the University of Pennsylvania School of Medicine. He directs the Sleep, Neurobiology and Psychopathology lab at Penn. He has an active research program exploring the mechanisms and treatment of sleep and circadian dysregulation in the context of mental health disorders. Dr. Gehrman's clinical specialization is on the delivery of cognitive behavioral and chronotherapeutic interventions for insomnia, circadian rhythm disorders, and other sleep disorders. The overarching goal of his work is to advance the understanding of the links between sleep and mental illness through translational research that spans biology to therapeutics.Resources mentioned in this episode: STOP Screening tool for Obstructive Sleep Apnea: https://deploymentpsych.org/content/insomnia-toolsMotivational Interviewing for CPAP Adherence: Rapelli G, Pietrabissa G, Manzoni GM, Bastoni I, Scarpina F, Tovaglieri I, Perger E, Garbarino S, Fanari P, Lombardi C and Castelnuovo G (2021) Improving CPAP Adherence in Adults With Obstructive Sleep Apnea Syndrome: A Scoping Review of Motivational Interventions. Front. Psychol. 12:705364. doi: 10.3389/fpsyg.2021.705364Motivational Interviewing resources: https://deploymentpsych.org/Clinical-Skills-ResourcesSystematic desensitization: https://www.veterantraining.va.gov/insomnia/docs/PAP_Desensitization.pdfPractical for Your Practice voice mail: speakpipe.com/cdpp4pPractical for Your Practice email: cdp-podcast-ggg@usuhs.edu Calls-to-action: Incorporate the STOP into your practiceBecome familiar with behavioral and motivational approaches listed aboveConnect with your local sleep medicine clinicReach out to us via Speakpipe with your questions and commentsSubscribe to the Practical for Your Practice PodcastSubscribe to The Center for Deployment Psychology Monthly Email at https://deploymentpsych.org/CDP-MED-Opt-In

Sleep Apnea or Obstructive Sleep Apnea, is a phenomenon that many people do not understand nor associate with significant disease due to the fears of diagnosis and therapy. Sleep apnea or obstructive sleep apnea is a cause of significant fatigue, brain fog, lack of concentration, and other common symptoms. Sleep Apnea is a cause of cardiovascular disease, such as heart attack, stroke, congestive heart, failure, stroke, treatment resistant, hypertension, and many other diseases. Do not underestimate how this disease can affect quality and quantity of life. Learn more with today’s podcast on OSA. See omnystudio.com/listener for privacy information.

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss an overview of OSA. In Part 2 we will take a deep dive into diagnosis, Part 3 will discuss treatment options, and Part 4 will look at cases. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Paul Doghramji, MD – Medical Director of Health Services at Ursinus College, Attending Family Physician at Collegeville Family Practice Selected references: Diagnosis and Management of Obstructive Sleep Apnea - A Review. JAMA. 2020;323(14):1389-1400 Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments.  Sleep Medicine Reviews 2024;78:1-12

Sleep apnea is a condition that affects millions of people, often without them even knowing it. It's more than just loud snoring or restless nights. It can have serious health consequences. And the state Office of Cannabis Management has new data about using cannabis to treat the condition. They conducted the largest survey on record about the condition and cannabis. And their findings show it could really help patients. Joining Minnesota Now to explain is Grace Christensen, a research analyst at the Office of Cannabis Management.

Tem gente que dorme de lado. Outras pessoas preferem a barriga pra cima. Outras gostam da barriga pra baixo. Braço esticado. Perna dobrada. Com ou sem coberta... Afinal, a posição e o jeito como dormimos tem alguma relação com nossa personalidade ou nosso estado, segundo a ciência?Confira o papo entre o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.>> OUÇA (52min 35s)*Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.Edição: Reginaldo Cursino.http://naruhodo.b9.com.br*APOIO: INSIDERIlustríssima ouvinte, ilustríssimo ouvinte do Naruhodo, chegou abril, o mês de aniversário da INSIDER!E adivinha quem sai ganhando? Quem entende que menos é mais! Ou seja: você e eu!Você já sabe que eu uso INSIDER há anos, tanto para o trabalho quanto para o lazer. Porque eu quero menos consumo por impulso, mais peças que duram e uma moda que valorize o meu estilo pessoal.E eu sei que você tava só esperando uma desculpa pra comprar aquela camiseta da INSIDER que eu vivo usando e sobre a qual vivo falando bem... Então, vem experimentar INSIDER você também!Em abril, o cupom NARUHODO mais os descontos do site podem chegar a até 30% de desconto. É isso mesmo: 30% de desconto!Para aproveitar, o jeito mais fácil é usar o endereço https://bit.ly/naruhodo-abril-2025 ou clicar no link da descrição deste episódio: o cupom será aplicado automaticamente no carrinho.INSIDER: inteligência em cada escolha.#InsiderStore*APOIO: HOMO ACADEMICUSAqui no Naruhodo, a gente vive falando sobre as dificuldades da vida acadêmica. Ao mesmo tempo, a gente acredita que ela pode ser mais legal e menos solitária.Por isso temos a felicidade de divulgar um projeto admirável: o HOMO ACADEMICUS.O HOMO ACADEMICUS surge como um esforço comunitário que ambiciona inspirar as pessoas a buscar outras formas de viver a universidade. Que une pessoas de vários países da América Latina, como Brasil, Peru, Chile, Equador, Argentina e México. E também diferentes áreas do conhecimento e habilidades, como de escrita, edição, tradução, design e pesquisa.Ele é um podcast? É. Traz temas como as regras não ditas da universidade, gestão do tempo, violência na universidade, comunidades de pesquisas, escrita acadêmica, entre outros.Mas HOMO ACADEMICUS é também muito mais que um podcast, e será cada vez mais. É capacitação, é reflexão, é diálogo.E traz ainda uma ideia muito bacana: os Clubes de Escuta, que são redes de apoio que vocês - estudantes, pesquisadores e professores - podem criar para discutirem os desafios de seus contextos, usando como suporte os recursos que são preparados para cada episódio.Então conheça hoje mesmo essa belíssima iniciativa:homoacademicus.org*REFERÊNCIASDormir de lado ativa sistema glinfático e é melhor para o cérebrohttps://search.app/qpGVbN6cmZTwP4sr8Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleephttps://www.science.org/doi/10.1126/science.aax5440The Effect of Body Posture on Brain Glymphatic Transporthttps://www.jneurosci.org/content/35/31/11034Sleep positions and nocturnal body movements based on free-living accelerometer recordings: association with demographics, lifestyle, and insomnia symptomshttps://pubmed.ncbi.nlm.nih.gov/29138608/The Glymphatic System: A Novel Component of Fundamental Neurobiologyhttps://www.jneurosci.org/content/41/37/7698.abstractA Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trialhttps://pubmed.ncbi.nlm.nih.gov/26053170/Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002https://pubmed.ncbi.nlm.nih.gov/15843394/Influence of the right- versus left-sided sleeping position on the apnea-hypopnea index in patients with sleep apneahttps://pubmed.ncbi.nlm.nih.gov/21678115/High Negative Predictive Value of Normal Body Mass Index for Obstructive Sleep Apnea in the Lateral Sleeping Positionhttps://pubmed.ncbi.nlm.nih.gov/29852898/Sleep positions and personality: Zuckerman-Kuhlman's big five, creativity, creativity styles, and hypnotizabilityhttps://www.researchgate.net/publication/287884030_Sleep_positions_and_personality_Zuckerman-Kuhlman's_big_five_creativity_creativity_styles_and_hypnotizabilityUpper airway obstruction during sleep in infants with laryngomalacia is frequently sleep-position-dependenthttps://www.nature.com/articles/s41390-025-03919-zFactors Related to the Sleep Duration of 3-Month-Old Infantshttps://www.thieme-connect.com/products/ejournals/html/10.1055/s-0044-1782168Sleep positions : the night language of the bodyhttps://archive.org/details/sleeppositionsni00dunk/page/n5/mode/2upThe contribution of prone sleeping position to the racial disparity in sudden infant death syndrome: the Chicago Infant Mortality Studyhttps://pubmed.ncbi.nlm.nih.gov/12359794/Naruhodo #129 - Sono polifásico funciona segundo a ciência?https://www.youtube.com/watch?v=h6AfuI46VhQNaruhodo #188 - Contar carneirinhos faz a gente dormir mais rápido?https://www.youtube.com/watch?v=Txu8-QTZB7INaruhodo #191 - É possível aprender idiomas dormindo?https://www.youtube.com/watch?v=nz1FoXN8XqANaruhodo #256 - Por que roncamos?https://www.youtube.com/watch?v=SfJH_F2GsI4Naruhodo #153 - Sonambulismo tem cura?https://www.youtube.com/watch?v=ghcxHlIK5RINaruhodo #156 - O que é paralisia do sono?https://www.youtube.com/watch?v=h9om8soj_uANaruhodo #138 - O que é bruxismo do sono?https://www.youtube.com/watch?v=CFVyaXRNs0QNaruhodo #123 - O que é e como funciona o sonho lúcido?https://www.youtube.com/watch?v=ThUlmkFFr1UNaruhodo #83 - O que são sonhos?https://www.youtube.com/watch?v=rKvDGxCg7XENaruhodo #297 - Balançar de um lado para o outro ajuda a dormir melhor?https://www.youtube.com/watch?v=LvuqqtayK60Naruhodo #318 - Por que algumas pessoas acordam de mau humor?https://www.youtube.com/watch?v=PKvR_lr5ZIw*APOIE O NARUHODO!O Altay e eu temos duas mensagens pra você.A primeira é: muito, muito obrigado pela sua audiência. Sem ela, o Naruhodo sequer teria sentido de existir. Você nos ajuda demais não só quando ouve, mas também quando espalha episódios para familiares, amigos - e, por que não?, inimigos.A segunda mensagem é: existe uma outra forma de apoiar o Naruhodo, a ciência e o pensamento científico - apoiando financeiramente o nosso projeto de podcast semanal independente, que só descansa no recesso do fim de ano.Manter o Naruhodo tem custos e despesas: servidores, domínio, pesquisa, produção, edição, atendimento, tempo... Enfim, muitas coisas para cobrir - e, algumas delas, em dólar.A gente sabe que nem todo mundo pode apoiar financeiramente. E tá tudo bem. Tente mandar um episódio para alguém que você conhece e acha que vai gostar.A gente sabe que alguns podem, mas não mensalmente. E tá tudo bem também. Você pode apoiar quando puder e cancelar quando quiser. O apoio mínimo é de 15 reais e pode ser feito pela plataforma ORELO ou pela plataforma APOIA-SE. Para quem está fora do Brasil, temos até a plataforma PATREON.É isso, gente. Estamos enfrentando um momento importante e você pode ajudar a combater o negacionismo e manter a chama da ciência acesa. Então, fica aqui o nosso convite: apóie o Naruhodo como puder.bit.ly/naruhodo-no-orelo

Did you know that primary care clinicians are in the perfect position to identify and even manage obstructive sleep apnea (OSA)? Credit available for this activity expires: 4/16/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002444?ecd=bdc_podcast_libsyn_mscpedu

Host Amy Attaway, MD, (Cleveland Clinic) is joined by two leaders in sleep medicine— Neomi Shah, MD, MPH,  (Icahn School at Mount Sinai)  and Reena Mehra, MD, MS, ATSF (University of Washington)—to discuss the recent ATS Workshop Report: “The Great Controversy of OSA Treatment for Cardiovascular Risk: Advancing the Science Through Expert Consensus.”Together, they explore the complex relationship between obstructive sleep apnea (OSA) and cardiovascular outcomes. Workshop Report here: https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.202409-981ST09:45 What gaps have past studies brought to light regarding major cardiovascular events and OSA?                 11:59 How does the Report help inform discussions with patients?33:24 Is CPAP the answer?

Dr. Hoffman continues his conversation with Dr. Julie Siemers, a nurse educator and author of “Surviving Your Hospital Stay: A Nurse Educator's Guide to Staying Safe and Living to Tell About It.” 

Dr. Julie Siemers, a nurse educator and author of “Surviving Your Hospital Stay: A Nurse Educator's Guide to Staying Safe and Living to Tell About It,” details the importance of patient safety in hospitals, the dangers of medical errors, and how patients and their families can advocate for better care. Dr. Siemers talks about the critical role of nurses, the hierarchy within the nursing profession, and the importance of effective communication between healthcare providers and patients. She also offers practical advice on dealing with high-risk medications, leveraging AI in healthcare, and ensuring better health outcomes by being informed and proactive.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425 Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity.  Episode resource links: https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html https://emedicine.medscape.com/article/295807-overview Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... & Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... & US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950. https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/ Guest: Mariyan L. Montaque, DNP, FNP-BC  Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425 Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity.  Episode resource links: https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html https://emedicine.medscape.com/article/295807-overview Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... & Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... & US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950. https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/ Guest: Mariyan L. Montaque, DNP, FNP-BC  Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Magic pill for OSA? No mask? No hose? No implant?What's going on?The STT crew talks to John Cronin, MD, Senior Vice President, Apnimed. Dr Cronin tells us about his journey in the field of sleep medicine and his current project at Apnimed. The project is the world's first oral therapy for Obstructive Sleep Apnea. Dr Cronin tells us where Apnimed is in the process of getting the medication to patients' hands and a little about the story behind it.Listen in and learn more about the latest in OSA therapy.For more information visit https://apnimed.com/A huge thanks to our sponsors:Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/ReactHealth: reacthealth.comDon't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 95Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

What if the most common symptoms of obstructive sleep apnea in women aren't the ones doctors are trained to recognize? In this episode, Dr. Megan Durr, an otolaryngologist from the University of California San Francisco, discusses obstructive sleep apnea in women with host Dr. Gopi Shah.  The doctors explore how symptoms in women differ from men, leading to missed diagnoses. They delve into the lack of literature on the topic and the potential for underrepresented groups to be overlooked. The conversation highlights the need for more inclusive screening tools and the long-term cardiovascular risks women face due to untreated sleep apnea. Dr. Durr emphasizes the importance of better diagnosing and treating sleep apnea in women.  TIMESTAMPS 00:00 - Introduction  00:18 - Recognizing Obstructive Sleep Apnea in Women  00:36 - Pregnancy and Obstructive Sleep Apnea  01:13 - Menopause and Sleep Disorders  01:59 - Underrepresented Groups and OSA 02:47 - Symptoms and Misdiagnosis in Women  04:40 - Screening Questionnaires and Gender Bias  05:59 - Clinical Observations and Gender Disparities  09:39 - Long-term Effects of OSA in Women  CHECK OUT THE FULL EPISODE BackTable ENT Podcast Episode #182 Understanding OSA in Women with Dr. Megan Durr https://www.backtable.com/shows/ent/podcasts/182/understanding-osa-in-women

Inside the Hidden Battle: Dr. Chris Frueh & Rob Sweetman on "Operator Syndrome" and Military Mental Health In this week's compelling episode of the Team Never Quit Podcast, we welcome Dr. Chris Frueh, a distinguished clinical psychologist, professor of psychology, and published author with over 30 years of experience working with military veterans and active-duty personnel. Dr. Frueh shares his extensive expertise drawn from decades of clinical trials, epidemiology, historical insights, and neuroscience research. Listen as he unpacks his groundbreaking work on “Operator Syndrome” and reveals how this paradigm-shifting concept is transforming our understanding and treatment of the complex health, psychological, and interpersonal challenges faced by those in military special operations. Extensive Expertise: Over thirty years of professional experience with military veterans and active-duty personnel. Academic & Clinical Leadership: Clinical Psychologist, Professor of Psychology, and co-author of more than 300 scientific publications, including a graduate textbook on adult psychopathology. Innovative Research: Pioneering work on “Operator Syndrome”—a framework addressing the interrelated challenges emerging from a career in military special operations Influential Voice: Dr. Frueh has testified before the US Congress and served as a contractor for organizations such as the Department of Defense, Veterans Affairs, US State Department, and the National Board of Medical Examiners. Media Presence: His insights have been featured in top publications and cited by outlets like the Wall Street Journal, The Economist, Washington Post, Scientific American, and NBC News. Along with Dr Freud, Rob Sweetman brings much to the discussion. A former Navy SEAL with eight years of service, Rob faced numerous hidden injuries, including PTSD, Traumatic Brain Injury (TBI), Obstructive Sleep Apnea, and Insomnia. The loss of a teammate to suicide became a turning point in his life, driving him to dedicate himself to the study of sleep science, determined to make a difference in the lives of others.  Whether you're a veteran, a mental health professional, or simply interested in groundbreaking research that bridges military experience and psychology, this episode is a must-listen. Tune in to gain valuable insights and join the conversation on advancing care for our military community. In this episode you will hear: • Through the military, the VA system, we've completely screwed the pooch with PTSD. We've put everything on PTSD. (6:47) •  Because we've put that reliance on PTSD, we've not attended to sleep, and sleep apnea.  (7:22) • We've failed a generation of soldiers. (8:01) • Soldiers injure their brains in 2 ways. Impact forces that cause a concussion, but also the blasts have a shearing effect. That scars the glial cells in the nervous system. (8:21) • We need to overhaul our approach to how we take care of soldiers, and by the way, this also affects first responders. (9:49) • Soldiers fight their wars overseas (so far). Responders are in the streets of their home town. (10:08) • We, and I say we as the medical establishment, of which I've been a part of for 30 years, we've fucked it all up. We're not paying attention. (10:36) • We've put all the focus on the psychological without appreciating the physiological. (15:49) • There's a lot of powers in the pharmaceutical companies, insurance companies, and the hospitals that control the actions of doctors. (23:01) • You can't say that all sleep causes all mental [issues] and you can't say that all mental health [issues] causes sleep health, but they're definitely related. (24:55) • We still don't have suicide figured out. (26:26) • You gotta have discipline. (32:22) • A hypnogram is how we measure sleep with brain wave activity. (41:57) • We have the best fighting force in the world. But we've been playing in the sand box of Iraq and Afghanistan. What's gonna happen when we have our first word threat. When that pops up, are we gonna be ready? (51:45) • Mr. Hegseth's number one mission is to improve the lethality of the war fighter. (56:26) • Last year, the VA spent 600 million dollars on suicide prevention efforts, that did not move the needle one little bit. (59:52) • The concept of Operator Syndrome is not a diagnosis, it's a framework for understanding how they're all interrelated. (63:25) • Your sleep affects your metabolism; it affects your hormone production. Testosterone is produced during sleep. Your brain health is affecting your sleep and your sleep is affecting your brain health. (63:38) Socials: - IG: Sleepgenius - https://ballastbooks.com/purchase/operator-syndrome/ Support TNQ - IG: team_neverquit , marcusluttrell , melanieluttrell , huntero13 -  https://www.patreon.com/teamneverquit Sponsors:   - shipsticks.com/TNQ    - Navyfederal.org           - Robinhood.com/gold    - strawberry.me/TNQ    - stopboxusa.com {TNQ}    - ghostbed.com/TNQ [TNQ]   -  kalshi.com/TNQ    - PXG.com/TNQ   -  joinbilt.com/TNQ    - Tonal.com [TNQ]   - greenlight.com/TNQ   - PDSDebt.com/TNQ   - drinkAG1.com/TNQ   - Shadyrays.com [TNQ]   - qualialife.com/TNQ [TNQ]   - Hims.com/TNQ   - Shopify.com/TNQ   - Aura.com/TNQ   - Policygenius.com   - TAKELEAN.com [TNQ]   - usejoymode.com [TNQ]   - Shhtape.com [TNQ]

From Pickwickian Syndrome to Sleep Disordered Breathing, Obstructive Sleep Apnea, OSA, and everything in between. Well it all started with a vacuum cleaner!Meet Dr Peter Farrell, founder and former CEO of Resmed; the little company we all know very well! Dr Farrell tells about his time in university in Australia, then at MIT, and finally meeting with Dr Collin Sullivan to develop the first commercially available CPAP machine. Learn the fascinating origin story of the CPAP and how Resmed grew from 9 people to the 10,000 person multinational company we know today. For more information vistit resmed.comA huge thanks to our sponsors:Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Don't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 94Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

In this episode, host Dr. Seema Khosla tackles a critical question in sleep medicine: What defines "well-treated" obstructive sleep apnea? Joined by Dr. Barry Krakow, a pioneering sleep medicine physician, the discussion explores the nuanced approach to assessing sleep apnea treatment beyond traditional metrics.  Discover insights into clinical endpoints for evaluating OSA treatment, the complex relationship between upper airway collapsibility and anxiety, and innovative strategies for patients with challenging sleep disorders. Dr. Krakow shares his unique perspectives on PAP therapy, including approaches for patients with PTSD and the potential role of behavioral interventions. 

Today, Drs. Alexis Lugo and Lauren Beckmeyer discuss Tuberculosis Outbreak in Kansas City, more on Sleep Habits in Children, and Snoring or Obstructive Sleep Apnea.   Time Stamps: 2:07 - Health News Segment 4:30 - Healthy Sleep Habits 10:54 - Parenting Tip 13:05 - Obstrustive Sleep Apnea 17:44 - Trivia

Show Notes for Episode 42 of “The 2 View” – Pink cocaine, holiday heart syndrome, pertussis, research updates on Zepbound and Semaglutide, and much more. Segment 1 – Pink cocaine What is Pink Cocaine? Dea.gov. DEA: United States Drug Enforcement Administration. https://www.dea.gov/pink-cocaine What is Pink Cocaine? Poison.org. POISON CONTROL: National Capital Poison Center. https://www.poison.org/articles/pink-cocaine Segment 2 – Holiday heart syndrome Blackburn R, Ajetunmobi O, Mc Grath-Lone L, et al. Hospital admissions for stress-related presentations among school-aged adolescents during term time versus holidays in England: weekly time series and retrospective cross-sectional analysis. BJPsych Open. Cambridge University Press. Cambridge Core. Published November 19, 2021. https://www.cambridge.org/core/journals/bjpsych-open/article/hospital-admissions-for-stressrelated-presentations-among-schoolaged-adolescents-during-term-time-versus-holidays-in-england-weekly-time-series-and-retrospective-crosssectional-analysis/924EE2CD1A8CFAC30E7090674FCEAF72 Carey M, Al-Zaiti S, Kozik T, Pelter M. Holiday Heart Syndrome. ECG Puzzler. Researchgate.net. AJCC: American Journal of Critical Care. American Association of Critical-Care Nurses. https://www.researchgate.net/profile/Mary-Carey/publication/260446497HolidayHeart_Syndrome/links/573dda6308ae298602e6d0b1/Holiday-Heart-Syndrome.pdf Ettinger P, Wu C, De La Cruz Jr C, Weisse A, Ahmed S, Regan T. Arrhythmias and the “Holiday Heart”: Alcohol associated cardiac rhythm disorders. Sciencedirect.com. ScienceDirect. American Heart Journal. https://www.sciencedirect.com/science/article/abs/pii/000287037890296X Greenspon AJ, Schaal SF. The “holiday heart”: electrophysiologic studies of alcohol effects in alcoholics. Ann Intern Med. PubMed. NIH: National Library of Medicine: National Center for Biotechnology Information. Published February 1983. https://pubmed.ncbi.nlm.nih.gov/6824246/ Jain A, Yelamanchili V, Brown K, Goel A. Holiday Heart Syndrome. Nih.gov. NIH: National Library of Medicine: National Center for Biotechnology Information. Updated January 16. 2024. https://www.ncbi.nlm.nih.gov/sites/books/NBK537185/ Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. AHA | ASA Journals. Published November 30, 2023. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193 Segment 3 – Pertussis CDC. About Whooping Cough. Whooping Cough (Pertussis). Updated April 2, 2024. https://www.cdc.gov/pertussis/about/index.html Center for Drug Evaluation, Research. FDA Drug Safety Communication: Death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age. FDA: U.S. Food and Drug Administration. Published June 28, 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-death-resulting-overdose-after-accidental-ingestion-tessalon Pertussis. Who.int. World Health Organization. https://www.who.int/health-topics/pertussis Simma L, Gesch M. Eyelid Ecchymoses and Subconjunctival Hemorrhage in Pertussis. N Engl J Med. Published December 11, 2024. https://www.nejm.org/doi/full/10.1056/NEJMicm2409052 Something sweet – Research updates: Zepbound and Semaglutide Ernst D. Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity. Monthly Prescribing Reference. MPR: Medical Professionals Reference. Published December 20, 2024. https://www.empr.com/news/zepbound-approved-for-obstructive-sleep-apnea-in-patients-with-obesity/?utmsource=eloqua&utmmedium=email&utmcampaign=NWLTRMPRTOPTDrug-DatabaseSS-LAS-LI1-LI2-9654122924_AL&hmemail=1f%2FJfEV7hN5vJr6vg%2FQRqK0NA6IXtyO3&sha256email=092493d8223fdfa40d9e995176d13e5fc5b5211674db9deb440c025fd462c80c&hmsubid=&nid=1639413404&elqtrack=True Semaglutide shows promise as a potential alcohol use disorder medication. Research Update. Nih.gov. NIH: National Institute on Alcohol Abuse and Alcoholism. Published March 13, 2024. https://www.niaaa.nih.gov/news-events/research-update/semaglutide-shows-promise-potential-alcohol-use-disorder-medication Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share! Looking forward to another year together!

Visit www.magicmind.com/highyieldjan for 45% off! VISIT US AT ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠NCLEXHIGHYIELD.COM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ No matter where you are in the world, or what your schedule is like, access the entire course at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.NCLEXHighYieldCourse.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  The NCLEX High Yield Podcast was featured on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Top 15 NCLEX Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Make sure you ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠JOIN OUR NEW VIP FACEBOOK GROUP!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://nclexhighyield.com/blogs/news/nclex-high-yield-quick-links⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ A topic that confuses many, but listen to how Dr. Zeeshan breaks this bad boy down! Many people get overwhelmed with all the information that's out there, we keep it simple! Join us weekly for FREE Zoom Sessions and be one of the many REPEAT test takers that passed the exam by spending NO MONEY with NCLEX High Yield! NCLEX High Yield is a Prep Course and Tutoring Company started by Dr. Zeeshan in order to help people pass the NCLEX, whether it's the first time , or like the majority of our students, it's NOT their first time. We keep things simple, show you trends and tips that no one has discovered, and help you on all levels of the exam! Follow us on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@NCLEXHighYield ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠or check out our website www.NCLEXHighYield.com Make sure you join us for our FREE Weekly Zoom Sessions! Every Wednesday 3PM PST / 6PM EST. Subscribe to our newsletter at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠nclexhighyield.com⁠⁠⁠⁠⁠⁠

Untreated obstructive sleep apnea in children can be associated with growth, developmental, and cardiopulmonary complications. Surgical options to treat OSA in children are constantly evolving, from not only new techniques on the traditional adenotonsillectomy to newer surgical techniques in older children.

Send us a textHappy Holidays Rounds Table Listeners! For our penultimate episode of 2024, we are back with a special treat! This week, Drs. Mike and John Fralick chat about the top five RCTs published over the past year:Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (0:00 – 3:40).Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (3:40 – 9:00).Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (9:00 – 13:55).Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (13:55 – 20:00).Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (the Balance Trial) (20:00 – 23:30).And for the Good Stuff:Toronto Star Santa Claus Fund, Calgary Food Bank, Epilepsy Canada (23:30 – 24:51).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePodsSupport the show

Happy Holidays Rounds Table Listeners! For our penultimate episode of 2024, we are back with a special treat! This week, Drs. Mike and John Fralick chat about the top five RCTs published over the past year:Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (0:00 – 3:40).Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (3:40 – 9:00).Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (9:00 – 13:55).Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (13:55 – 20:00).Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (the Balance Trial) (20:00 – 23:30).And for the Good Stuff:Toronto Star Santa Claus Fund, Calgary Food Bank, Epilepsy Canada (23:30 – 24:51).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Dr. John Fleetham chats with Dr. Ludovico Messineo and Dr. Simon Joosten about their articles "Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis" and "The Arousal Threshold: The ‘Weakest Link' in OSA Pathogenesis." 

A good night's rest is vital to our overall health, but there's a lot that can interrupt the 7 hours of sleep recommended for adults, including obstructive sleep apnea. Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for people with sleep apnea. Host Dr. Justin Clark and his guests discuss sleep apnea and treatment options on this Line One.

Sleep apnea is a sleep disorder characterized by repeated interruptions in breathing during sleep. Obstructive sleep apnea (OSA) is the most common type of sleep apnea, characterized by repeated episodes of partial or complete blockage of the airway during sleep. These blockages occur when the muscles at the back of the throat relax excessively, causing the airway to narrow or close, and momentarily stopping breathing. This condition contrasts with central sleep apnea, where the brain fails to send proper signals to the muscles that control breathing. When the brain is deprived of oxygen during sleep, OSA can lead to a number of serious conditions affecting not only quality of life, but brain health and function. It is important to seek medical attention.Omid B. Mehdizadeh, MD, is an otolaryngology-head & neck (ENT) surgeon with particular expertise in voice, swallowing and airway conditions at Pacific Neuroscience Institute (PNI). A Los Angeles native, his career has spanned treating world-class opera and Broadway singers to surgical mission trips serving underprivileged and indigenous populations of Central America. Outside PNI, he has focused his time on educating medical and undergraduate students and providing medical care to disenfranchised populations through community clinics.

Section Head of Surgical Sleep and Snoring Alan Kominsky, MD provides a deep dive into the evolution of surgical sleep therapy, including soft tissue surgery, to the current gold standard of hypoglossal nerve stimulation, to more innovations on the horizon.

If you suffer from sleep apnea, you can breathe easy knowing Texas Sinus & Snoring is on the case. Call them at (346) 413-9313 or visit https://texassinusandsnoring.com to learn more about the treatments they offer to alleviate sleep apnea and improve your nasal health! Texas Sinus and Snoring City: Spring Address: 2940 Farm to Market 2920 Website: https://texassinusandsnoring.com/ Phone: +1 346 413 9313 Email: Info@texassinusandsnoring.com

Need fast results for your sleep apnea? A guide from At Home Sleep Apnea Testing explains the importance of early detection. Visit https://athomesleepapneatesting.com/importance-of-early-detection-home-sleep-apnea-testing for details. At Home Sleep Apnea Testing City: Thousand Oaks Address: 317 S. Moorpark Rd, Thousand Oaks, CA 91361 Website: https://athomesleepapneatesting.com/ Phone: +1 805 557 9930 Email: support@athomesleepapneatesting.com

In this Respiratory edition of the Industry Matters podcast, Boone Lockard, VP of Respiratory chats with Chris Abad, Product Manager, Fisher & Paykel Healthcare, about Obstructive Sleep Apnea (OSA), treatment, and their new product, F&P Solo Pillows.

In this Respiratory edition of the Industry Matters podcast, Boone Lockard, VP of Respiratory chats with Chris Abad, Product Manager, Fisher & Paykel Healthcare, about Obstructive Sleep Apnea (OSA), treatment, and their new product, F&P Solo Pillows.

Want to avoid the hassle of a sleep lab? At Home Sleep Apnea Testing explains the role of technology in providing quick results and diagnoses for sleep apnea through accessible home testing tools you can use in your home. Visit https://athomesleepapneatesting.com/the-role-of-technology-in-home-sleep-apnea-testing for details. At Home Sleep Apnea Testing City: Thousand Oaks Address: 317 S. Moorpark Rd, Thousand Oaks, CA 91361 Website: https://athomesleepapneatesting.com/ Phone: +1 805 557 9930 Email: support@athomesleepapneatesting.com

The OMS Foundation Dr. David Stanton Resident Research Award recognizes the author of the most outstanding resident research paper published in the Journal of Oral and Maxillofacial Surgery during the previous year. The 2024 award recipient Dr. Corissa Chang along with Dr. Stanley Liu discuss the winning research.  Disclaimer 

Imagine waking up refreshed after a full night's sleep, free from the constant interruptions of obstructive sleep apnea (OSA). Now, imagine treating your OSA without relying on a bulky CPAP machine but with a convenient once-weekly injectable medication instead. Enter tirzepatide, the breakthrough peptide originally designed for diabetes and weight loss, is now making waves in treating OSA.  Recent studies reveal that tirzepatide (Mounjaro, Zepbound)  reduces apnea episodes and promotes significant weight loss, tackling one of the root causes of sleep apnea.  In this podcast, we'll talk about the science behind this exciting new study. Tirzepatide is a dual agonist that acts like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). GLP-1 and GIP are hormones naturally produced in the gut.  These hormones are important in regulating blood sugar levels, insulin secretion, and appetite control, which is why tirzepatide was first developed for type 2 diabetes and obesity management. By mimicking these hormones, tirzepatide enhances insulin sensitivity, reduces glucagon levels, and slows gastric emptying, which collectively aids in appetite suppression and promotes significant weight loss. The connection between tirzepatide and obstructive sleep apnea (OSA) lies in its ability to reduce body weight. OSA is often exacerbated by excess fat around the neck and airway, which leads to airway obstruction during sleep.  Weight loss is one of the most effective non-surgical treatments for OSA because it reduces this physical pressure, allowing the airway to stay open during sleep. By helping patients lose a substantial amount of weight, tirzepatide can reduce the severity of OSA symptoms. The latest publication from the New England Journal of Medicine (NEJM) discusses the impact of tirzepatide on obstructive sleep apnea (OSA) in individuals with obesity. Tirzepatide was tested in the SURMOUNT-OSA trial to determine its effect on OSA. The study showed that tirzepatide significantly reduced the severity of OSA over one year. The primary measurement was the Apnea-Hypopnea Index (AHI), which tracks the number of breathing interruptions per hour during sleep. In the trials, participants experienced a reduction in AHI by up to 56% compared to placebo. Additionally, body weight decreased by 16-17%, which is notable since weight loss directly improves OSA symptoms. Beyond the improvements in sleep quality, the study also observed benefits like reduced blood pressure, which could have positive cardiovascular implications for patients with OSA. But, further research is needed to determine whether these improvements lead to long-term reductions in cardiovascular events. Tirzepatide's effectiveness in treating OSA provides a promising new avenue for managing the condition, especially for patients who struggle with conventional therapies like CPAP or want to avoid oral facial surgery.  The full clinical impact of tirzepatide on patient-centered outcomes, such as quality of life and long-term health benefits, is still under investigation. While initial studies show promising improvements in sleep apnea severity and weight loss, more research is needed to fully understand its effects on broader health markers and long-term outcomes.  Additional trials will determine whether these short-term benefits translate into sustained improvements in overall health, quality of life, and reduced risks of associated conditions such as cardiovascular disease​. Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week! We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.  Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA 2024. Discussion by:Guest:Stephen Salloway, MD Director of Neurology and the Memory and Aging Program at Butler Hospital Professor of Psychiatry and Professor of Neurology at the Warren Alpert Medical School of Brown University. 2. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity - (The SURMOUNT OSA Trial) – NEJM 2024. Discussion by:Guest:Atul Malhotra, MD Professor of Pulmonary Critical Care & Sleep Medicine Previous at the University of California, San Diego.3. Relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of the evidence. Journal of Infection July 2024. https://doi.org/10.1016/j.jinf.2024.106187 Discussion by: Guest:Anupriya Grover-Wenk, MDFaculty– Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode, Dr. Valentin Fuster reviews a groundbreaking study comparing metabolic surgery to traditional care for patients with obesity and obstructive sleep apnea. The research shows that metabolic surgery significantly lowers the risk of major cardiovascular events and mortality, highlighting the need for a multifaceted approach to treating these interlinked conditions.

Live Nursing Review with Regina MSN, RN! Every Monday & Wednesday we are live. LIKE, FOLLOW, & SUB @ReMarNurse for more.       ►Back To School | Free Nursing Event - https://remarnurse.com/backtoschool ► 50% Discount on NCLEX V2 - https://study.remarnurse.com/vit/ ► Get Quick Facts Next Gen - https://bit.ly/QF-NGN ► Subscribe Now - http://bit.ly/ReMar-Subscription ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   Quick Facts for NCLEX Next Gen Study Guide here - https://bit.ly/QF-NGN Study with Professor Regina MSN, RN every Monday as you prepare for NCLEX Next Gen.   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN. ReMar is the #1 content-based NCLEX review and has helped thousands of repeat testers pass NCLEX with a 99.2% student success rate! ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students to pass boards - fast!

Roger Seheult, MD of MedCram examines the data related to using adhesive tape over the mouth as a treatment for obstructive sleep apnea. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on August 6th, 2024) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #mouthtape #sleepapnea #osa

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.     Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes 2.     Association between the Burden of Microvascular Disease and Cardiorespiratory Fitness among Adults with Type 2 Diabetes 3.     Association of metabolic syndrome with neuroimaging and cognitive outcomes 4.     Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity 5.     Semaglutide and Cardiovascular Outcomes by Baseline HbA and Change in HbA in SELECT   For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss. The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.HostJen Moulton, BSPharmPresident, CEimpactGuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.0.05 CEU/0.5 HrUAN: 0107-0000-24-238-H01-PInitial release date: 07/29/2024Expiration date: 07/29/2025Additional CPE details can be found here.

Recap and review the top pearls from episodes #1 (AND #100) Cystic Fibrosis, #11 Pneumonia, and #104 Obstructive Sleep Apnea with a few members of our production team! It's Fables from the Cribside! (FFTC), our series providing a rapid review of recent Cribsiders episodes for your spaced learning.

In this episode Teresa Power DeNike joins the podcast to chat about nasal breathing, obstructive sleep apnea, and how the dental hygienist plays a role in assessment and treatment for patients. This should be a key part of everyone's practice because not only does it save lives, but can be a profit center not yet realized. Don't miss this episode and be sure to come back for part 2 next week! If you want to reach out to Teresa you can find her on instagram -  @sleepbetternyc or check out the website that has so many resources - Sleepbetter.nyc

Welcome back Rounds Table Listeners!We are back today with a solo episode with Dr. Mike Fralick!This week, he will discuss a recent paper exploring the efficacy of tirzepatide in treating obstructive sleep apnea and obesity. Here we go!Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityCheck out the New Motto!Questions? Comments? Feedback? We'd love to hear from you! @roundstable

Obstructive Sleep Apnea: How the Dental Professional Can Intervene By Brooke Sergent, RDH, BS Original article published on Today's RDH: https://www.todaysrdh.com/obstructive-sleep-apnea-how-the-dental-professional-can-intervene/ Need CE? Start earning CE credits today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠⁠⁠⁠⁠⁠

Tirzepatide may be a good option if you have obesity and obstructive sleep apnea.Click here to read the study

Dr. Zaghi graduated from Harvard Medical School, completed residency in ENT (Otolaryngology- Head and Neck Surgery) at UCLA, and Sleep Surgery Fellowship at Stanford University. The focus of his sub-specialty training is on the comprehensive treatment of tongue-tie, nasal obstruction, mouth breathing, snoring, and obstructive sleep apnea. He is very active in clinical research relating to sleep disordered breathing with over 80+ peer-reviewed research publications in the fields of neuroscience, head and neck surgery, and sleep-disordered breathing.Dr. Zaghi is particularly interested in studying the impact of tethered-oral tissues (such as tongue-tie) and oral myofascial dysfunction on maxillofacial development, upper airway resistance syndrome, and obstructive sleep apnea. He is an invited lecturer, author, and journal reviewer for topics  relating to the diagnosis and management of sleep-disordered breathing and tongue-tie disorders.Research interests include: Study design, literature review, and statistical analysis. Special interest in collaborative and multidisciplinary research projects relating to airway and breathing disorders, obstructive sleep apnea, nasal obstruction, upper airway resistance syndrome, pediatric sleep disorders, myofunctional therapy, frenuloplasty, facial and airway development, and maxillofacial reconstructive surgery.Clinical interests: Sleep and Breathing Disorders, Tongue-tie, Snoring, Obstructive Sleep Apnea, Nasal Obstruction, Upper Airway Resistance Syndrome, Inspiratory Flow Limitation, Sleep Endoscopy, Deviated Septum, Tonsil Hypertrophy, TMJ Pain, Teeth-grinding, Mouth Breathing, Frenuloplasty, Tonsillectomy, Septoplasty, Turbinate Reduction, Vivaer Nasal Valve Remodeling, Maxillary Skeletal Expansion, MMA Jaw Surgery. SHOWNOTES:

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Today, you'll learn about a nasal spray that could one day let those with sleep apnea toss out their CPAP machines, house paint that kills mosquitos, and the incredible giant redwoods… of England. Sleep Spray “A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: a randomized, blinded, trial.” by Amal M. Osman, et al. 2024. “Obstructive Sleep Apnea.” by Rob Newsom & Dr. Abhinav Singh. 2024. Insecticide Paint “Insecticide paint controls mosquito population up to 1 year, experiment shows.” by Stephanie Soucheray, MA. 2024. “Mosquito-Borne Human Viral Diseases: Why Aedes aegypti?” by Jeffrey R. Powell. 2018. “Insecticide paints: a new community strategy for controlling dengue and zika mosquito vectors in Cabo Verde.” by Lara Ferrero Gomez, et al. 2024. “Special insecticide paint may help curb zika and dengue fever outbreaks.” EurekAlert! 2024. UK Redwoods “Hidden giants: how the UK's 500,000 redwoods put California in the shade.” by James Tapper. 2024. “11 FActs About Coast Redwoods, the Tallest Trees in the World.” by Melissa Breyer. 2020. “California: visitors to world's tallest tree face $5,000 fine and possible jail time.” Associated Press. 2022. Hosted on Acast. See acast.com/privacy for more information.